Skip to main content Skip to section navigation Skip to footer
Trevena, Inc. Corporate Home
  • About
  • Pipeline
    • Overview
    • TRV045
    • TRV250
    • TRV734
  • Products
    • OLINVYK® (oliceridine) injection
  • Medical Affairs
    • Investigator-Initiated Trials
    • Contact Medical Information
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Info
    • Stock Info
    • Resources
    • Governance
  • Careers
  • Contact
    • Contact Medical Information
    • Whistleblower Hotline

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Financial Info
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Info
    • Quote
    • Analyst Coverage
    • IRS Form 8937
  • Resources
    • Email Alerts
    • Contacts
    • FAQ
  • Governance
    • Governance Documents

Trevena Announces Positive Results from Phase 1 Multiple Ascending Dose Study of TRV734 for Moderate to Severe Acute and Chronic Pain

Feb 9, 2015 7:00 am EST

Trevena CEO to Present at the 17th Annual BIO CEO & Investor Conference

Feb 3, 2015 4:01 pm EST

TRV027 Phase 2b BLAST-AHF Trial Design Published in Journal of the American College of Cardiology: Heart Failure

Feb 3, 2015 7:00 am EST

Trevena Initiates Second Phase 2b Study of TRV130 for Acute Postoperative Pain

Jan 6, 2015 4:01 pm EST

Trevena Appoints Anne M. Phillips to the Board of Directors

Dec 17, 2014 7:00 am EST

Trevena Announces Closing of Public Offering and Partial Exercise of Underwriters’ Option to Purchase Additional Shares

Dec 10, 2014 4:01 pm EST

Trevena Announces Pricing of Public Offering

Dec 4, 2014 7:00 pm EST

Trevena Announces Commencement of Public Offering

Dec 1, 2014 7:00 am EST

Trevena Announces Positive Top-Line Results from Phase 2a/b Study of TRV130 in Acute Postoperative Pain

Nov 17, 2014 4:01 pm EST

Trevena Reports Third Quarter 2014 Financial Results and Provides a Corporate Update

Nov 11, 2014 7:00 am EST
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • …
  • Page 35
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Sitemap
©2025 Trevena, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Terms of Use
  • Sitemap
  • Accessibility Statement